Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
John J. Bissler(Cincinnati Children's Hospital Medical Center), J.C. Kingswood(Royal Sussex County Hospital), Elżbieta Radzikowska, Bernard A. Zonnenberg(University Medical Center Utrecht), Michael Frost(Minnesota Epilepsy Group), Е. Д. Белоусова, Matthias Sauter(LMU Klinikum), Norio Nonomura(Osaka University Hospital), Susanne Brakemeier(Charité - Universitätsmedizin Berlin), Petrus J. de Vries(University of Cape Town), Vicky Whittemore(National Institutes of Health), David Chen(Novartis (United States)), Tarek Sahmoud(Novartis (United States)), Gaurav Shah(Novartis (United States)), Jeremie Lincy(Novartis (Switzerland)), David Lebwohl(Novartis (United States)), Klemens Budde(Charité - Universitätsmedizin Berlin)
Cited by 878
Abstract
Related Papers
No related papers found
Powered by citation graph analysis